Alfredo Budillon
IRCCS I.N.T. "G. Pascale · IRCCS I.N.T. "G. Pascale" · National Cancer Institute, Napoli
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alfredo Budillon as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:51 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05821556 · Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma PatientsNational Cancer Institute, Naples · recruiting · Adenocarcinoma of the Pancreas · principal investigator
- N/ANCT05817227 · Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.National Cancer Institute, Naples · recruiting · Breast Cancer · principal investigator
- Ph2NCT04310176 · Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal CancerNational Cancer Institute, Naples · unknown · Ras-mutated Metastatic Colorectal Cancer · study chair
- Ph2NCT02624128 · Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and NeckNational Cancer Institute, Naples · unknown · Squamous Cell Carcinoma of the Head and Neck · principal investigator
- Ph2NCT02619435 · Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal CancerNational Cancer Institute, Naples · unknown · Advanced Colorectal Cancer · principal investigator
- Ph1NCT00415779 · ZANTE: Zometa and Taxotere in Hormone Refractory Prostate CancerNational Cancer Institute, Naples · completed · Metastatic Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:51 UTC. The ranking covers the 200 most relevant of 22 PubMed records, and a shared surname and initials can bring in a namesake. All 22 on PubMed
- Mini-cardiopulmonary bypass system: results of a prospective randomized study.Ann Thorac Surg · 200663 citationsRCR 2.4
- 54 citationsRCR 1.8
- Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome.Eur J Nucl Med Mol Imaging · 201248 citationsRCR 1.7
- Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours.Cancer Chemother Pharmacol · 200647 citationsRCR 1.2
- 45 citationsRCR 1.6
- Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: phase I ZANTE trial.Cancer Biol Ther · 201041 citationsRCR 1.1
- Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer.Ann Oncol · 200039 citationsRCR 1.1
- 34 citationsRCR 0.9
- 33 citationsRCR 1.0
- Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial.JAMA Netw Open · 202127 citationsRCR 1.4